RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 88 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,119 | -1.6% | 22,107 | -3.9% | 0.01% | -16.7% |
| Q2 2023 | $171,832 | +21.7% | 23,003 | +8.7% | 0.01% | +20.0% |
| Q1 2023 | $141,144 | +9.9% | 21,161 | +27.0% | 0.01% | 0.0% |
| Q4 2022 | $128,418 | -44.4% | 16,656 | -23.3% | 0.01% | -50.0% |
| Q3 2022 | $231,000 | +13.2% | 21,707 | -3.8% | 0.01% | +11.1% |
| Q2 2022 | $204,000 | +16.6% | 22,562 | -4.1% | 0.01% | +28.6% |
| Q1 2022 | $175,000 | -24.2% | 23,524 | +50.7% | 0.01% | -22.2% |
| Q4 2021 | $231,000 | +5.5% | 15,606 | +52.3% | 0.01% | -10.0% |
| Q3 2021 | $219,000 | -22.3% | 10,247 | +46.0% | 0.01% | -28.6% |
| Q2 2021 | $282,000 | – | 7,020 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
| Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
| Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
| MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
| MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
| ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
| Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |